{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:57:22Z","timestamp":1777348642658,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.micpath.2020.104502","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T02:42:48Z","timestamp":1600137768000},"page":"104502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistance"],"prefix":"10.1016","volume":"149","author":[{"given":"Peiyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-7398","authenticated-orcid":false,"given":"Zhichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-2658","authenticated-orcid":false,"given":"Yiyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104502_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fmicb.2018.00437","article-title":"Group B streptococcal colonization, molecular characteristics, and epidemiology","volume":"9","author":"Shabayek","year":"2018","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2020.104502_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.tim.2017.05.013","article-title":"Perinatal group B streptococcal infections: virulence factors, immunity, and prevention strategies","volume":"25","author":"Vornhagen","year":"2017","journal-title":"Trends Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2020.104502_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216749","article-title":"Disease burden of neonatal invasive Group B Streptococcus infection in The Netherlands","volume":"14","author":"de Gier","year":"2019","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.micpath.2020.104502_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/JCM.01615-16","article-title":"Serotype distribution, population structure, and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women","volume":"55","author":"Teatero","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2020.104502_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2016.08.023","article-title":"Molecular characteristics and antimicrobial resistance in invasive and noninvasive Group B Streptococcus between 2008 and 2015 in China","volume":"86","author":"Lu","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Pt 10","key":"10.1016\/j.micpath.2020.104502_bib6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1099\/jmm.0.077057-0","article-title":"Macrolide- and tetracycline-resistance determinants of colonizing group B streptococcus in women in Egypt","volume":"63","author":"Shabayek","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2020.104502_bib7","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/ncomms5544","article-title":"Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline","volume":"5","author":"Da Cunha","year":"2014","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.micpath.2020.104502_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijantimicag.2018.01.001","article-title":"Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic\/pharmacodynamic analysis","volume":"51","author":"Thabit","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.micpath.2020.104502_bib9","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/AAC.00366-16","article-title":"Antibacterial efficacy of eravacycline in vivo against gram-positive and gram-negative organisms","volume":"60","author":"Monogue","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104502_bib10","first-page":"921","volume":"vol. 69","author":"Solomkin","year":"2019"},{"issue":"11","key":"10.1016\/j.micpath.2020.104502_bib11","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/AAC.01288-13","article-title":"Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens","volume":"57","author":"Sutcliffe","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41426-018-0141-y","article-title":"Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg. Microb. Infect."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12866-018-1349-7","article-title":"Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2020.104502_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.02465-15","article-title":"Potential of tetracycline resistance proteins to evolve tigecycline resistance","volume":"60","author":"Linkevicius","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.micpath.2020.104502_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/hsz-2013-0292","article-title":"Tetracycline antibiotics and resistance mechanisms","volume":"395","author":"Nguyen","year":"2014","journal-title":"Biol. Chem."},{"issue":"4","key":"10.1016\/j.micpath.2020.104502_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkv420","article-title":"Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)","volume":"71","author":"Fiedler","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.micpath.2020.104502_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnx284","article-title":"Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing","volume":"365","author":"Bai","year":"2018","journal-title":"FEMS Microbiol. Lett."},{"issue":"12","key":"10.1016\/j.micpath.2020.104502_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fny116","article-title":"In vitro-induced erythromycin resistance facilitates cross-resistance to the novel fluoroketolide, solithromycin, in Staphylococcus aureus","volume":"365","author":"Yao","year":"2018","journal-title":"FEMS Microbiol. Lett."},{"issue":"5","key":"10.1016\/j.micpath.2020.104502_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217602","article-title":"Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc","volume":"14","author":"Magallon","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2020.104502_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.anaerobe.2018.06.016","article-title":"In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species","volume":"52","author":"Goldstein","year":"2018","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.micpath.2020.104502_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02206-17","article-title":"Evaluation of the in vitro activity of eravacycline against a broad spectrum of recent clinical anaerobic isolates","volume":"62","author":"Snydman","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.diagmicrobio.2017.12.013","article-title":"In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015","volume":"91","author":"Zhanel","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2020.104502_bib24","article-title":"The efficacy and safety of eravacycline in the treatment of complicated intra-abdominal infections: a systemic review and meta-analysis of randomized controlled trials","volume":"8","author":"Lan","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12879-019-4093-1","article-title":"In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.micpath.2020.104502_bib26","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/jac\/dkv211","article-title":"Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA","volume":"70","author":"Lupien","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2020.104502_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00178-10","article-title":"Emergence and global dissemination of host-specific Streptococcus agalactiae clones","volume":"1","author":"S\u00f8rensen","year":"2010","journal-title":"mBio"},{"issue":"23","key":"10.1016\/j.micpath.2020.104502_bib28","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.23.20825","article-title":"Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV\/clonal complex 17 clone","volume":"19","author":"Florindo","year":"2014","journal-title":"Euro Surveill."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijmm.2018.10.005","article-title":"Molecular epidemiology of invasive and non-invasive group B Streptococcus circulating in Serbia","volume":"309","author":"Gajic","year":"2019","journal-title":"International journal of medical microbiology : IJMM."},{"issue":"9","key":"10.1016\/j.micpath.2020.104502_bib30","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/JCM.00277-10","article-title":"Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States","volume":"48","author":"Diedrick","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2020.104502_bib31","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ajic.2017.10.020","article-title":"Neonatal colonization of group B Streptococcus in China: prevalence, antimicrobial resistance, serotypes, and molecular characterization","volume":"46","author":"Guo","year":"2018","journal-title":"Am. J. Infect. Contr."},{"issue":"1","key":"10.1016\/j.micpath.2020.104502_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.04174-14","article-title":"Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium","volume":"59","author":"Cattoir","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020308688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020308688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:38:51Z","timestamp":1760110731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020308688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S0882401020308688"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104502","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistance","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104502"}}